<?xml version="1.0" encoding="utf-8"?>
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended" xmlns:xlink="http://www.w3.org/1999/xlink">
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_ActivosFinancierosAValorRazonableConCambiosEnOtroResultadoGlobalNota12" xlink:label="pharmamarsa_ActivosFinancierosAValorRazonableConCambiosEnOtroResultadoGlobalNota12" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_VentasDeAccionesNota17" xlink:label="pharmamarsa_VentasDeAccionesNota17" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_OtrosMovimientos" xlink:label="pharmamarsa_OtrosMovimientos" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_IngresosDiferidosSubvenciones" xlink:label="pharmamarsa_IngresosDiferidosSubvenciones" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_OtrosActivosYPasivos" xlink:label="pharmamarsa_OtrosActivosYPasivos" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_PartidasDiferidasODePeriodificacion" xlink:label="pharmamarsa_PartidasDiferidasODePeriodificacion" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_OtrosFlujosDeEfectivoDeLasActividadesDeExplotacion" xlink:label="pharmamarsa_OtrosFlujosDeEfectivoDeLasActividadesDeExplotacion" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_OtrosActivosFinancieros" xlink:label="pharmamarsa_OtrosActivosFinancieros" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_CobrosYPagosPorInstrumentosDePatrimonio" xlink:label="pharmamarsa_CobrosYPagosPorInstrumentosDePatrimonio" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_CobrosYPagosPorInstrumentosDePasivoFinanciero" xlink:label="pharmamarsa_CobrosYPagosPorInstrumentosDePasivoFinanciero" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_RiesgoDeTipoDeInteresDeLosFlujosDeEfectivoYDelValorRazonable" xlink:label="pharmamarsa_RiesgoDeTipoDeInteresDeLosFlujosDeEfectivoYDelValorRazonable" />
    <loc xlink:type="locator" xlink:href="959800QWKZ45ZQC2AV58-2023-12-31.xsd#pharmamarsa_DisclosureOfDutyOfLoyalty" xlink:label="pharmamarsa_DisclosureOfDutyOfLoyalty" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_ActivosFinancierosAValorRazonableConCambiosEnOtroResultadoGlobalNota12" xlink:to="label_pharmamarsa_pharmamarsaActivosFinancierosAValorRazonableConCambiosEnOtroResultadoGlobalNota12_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_ProfitLoss" xlink:to="label_pharmamarsa_ifrs-fullProfitLoss_PeriodStart" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_VentasDeAccionesNota17" xlink:to="label_pharmamarsa_pharmamarsaVentasDeAccionesNota17_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_OtrosMovimientos" xlink:to="label_pharmamarsa_pharmamarsaOtrosMovimientos_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_ProfitLoss" xlink:to="label_pharmamarsa_ifrs-fullProfitLoss_PeriodEnd" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="label_pharmamarsa_ifrs-fullComprehensiveIncome_PeriodEnd" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_IngresosDiferidosSubvenciones" xlink:to="label_pharmamarsa_pharmamarsaIngresosDiferidosSubvenciones_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_OtrosActivosYPasivos" xlink:to="label_pharmamarsa_pharmamarsaOtrosActivosYPasivos_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_PartidasDiferidasODePeriodificacion" xlink:to="label_pharmamarsa_pharmamarsaPartidasDiferidasODePeriodificacion_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_OtrosFlujosDeEfectivoDeLasActividadesDeExplotacion" xlink:to="label_pharmamarsa_pharmamarsaOtrosFlujosDeEfectivoDeLasActividadesDeExplotacion_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_OtrosActivosFinancieros" xlink:to="label_pharmamarsa_pharmamarsaOtrosActivosFinancieros_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_CobrosYPagosPorInstrumentosDePatrimonio" xlink:to="label_pharmamarsa_pharmamarsaCobrosYPagosPorInstrumentosDePatrimonio_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_CobrosYPagosPorInstrumentosDePasivoFinanciero" xlink:to="label_pharmamarsa_pharmamarsaCobrosYPagosPorInstrumentosDePasivoFinanciero_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="label_pharmamarsa_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_Total" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" priority="100" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_RiesgoDeTipoDeInteresDeLosFlujosDeEfectivoYDelValorRazonable" xlink:to="label_pharmamarsa_pharmamarsaRiesgoDeTipoDeInteresDeLosFlujosDeEfectivoYDelValorRazonable_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <labelArc xlink:type="arc" xlink:from="pharmamarsa_DisclosureOfDutyOfLoyalty" xlink:to="label_pharmamarsa_pharmamarsaDisclosureOfDutyOfLoyalty_Standard" order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" />
    <label xlink:label="label_pharmamarsa_pharmamarsaActivosFinancierosAValorRazonableConCambiosEnOtroResultadoGlobalNota12_Standard" id="pharmamarsa_pharmamarsaActivosFinancierosAValorRazonableConCambiosEnOtroResultadoGlobalNota12_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">- Activos financieros a valor razonable con cambios en otro resultado global (Nota 12)</label>
    <label xlink:label="label_pharmamarsa_ifrs-fullProfitLoss_PeriodStart" id="pharmamarsa_ifrs-fullProfitLoss_PeriodStart" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="es">Ganancia (pérdida)</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaVentasDeAccionesNota17_Standard" id="pharmamarsa_pharmamarsaVentasDeAccionesNota17_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Ventas de acciones (Nota 17)</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaOtrosMovimientos_Standard" id="pharmamarsa_pharmamarsaOtrosMovimientos_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Otros movimientos</label>
    <label xlink:label="label_pharmamarsa_ifrs-fullProfitLoss_PeriodEnd" id="pharmamarsa_ifrs-fullProfitLoss_PeriodEnd" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="es">Resultado 2023</label>
    <label xlink:label="label_pharmamarsa_ifrs-fullComprehensiveIncome_PeriodEnd" id="pharmamarsa_ifrs-fullComprehensiveIncome_PeriodEnd" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="es">Resultado global del ejercicio</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaIngresosDiferidosSubvenciones_Standard" id="pharmamarsa_pharmamarsaIngresosDiferidosSubvenciones_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Ingresos diferidos - subvenciones</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaOtrosActivosYPasivos_Standard" id="pharmamarsa_pharmamarsaOtrosActivosYPasivos_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Otros activos y pasivos</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaPartidasDiferidasODePeriodificacion_Standard" id="pharmamarsa_pharmamarsaPartidasDiferidasODePeriodificacion_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Partidas diferidas o de periodificación</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaOtrosFlujosDeEfectivoDeLasActividadesDeExplotacion_Standard" id="pharmamarsa_pharmamarsaOtrosFlujosDeEfectivoDeLasActividadesDeExplotacion_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Otros flujos de efectivo de las actividades de explotación</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaOtrosActivosFinancieros_Standard" id="pharmamarsa_pharmamarsaOtrosActivosFinancieros_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Otros activos financieros</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaCobrosYPagosPorInstrumentosDePatrimonio_Standard" id="pharmamarsa_pharmamarsaCobrosYPagosPorInstrumentosDePatrimonio_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Cobros y (pagos) por instrumentos de patrimonio</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaCobrosYPagosPorInstrumentosDePasivoFinanciero_Standard" id="pharmamarsa_pharmamarsaCobrosYPagosPorInstrumentosDePasivoFinanciero_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Cobros y (pagos) por instrumentos de pasivo financiero</label>
    <label xlink:label="label_pharmamarsa_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_Total" id="pharmamarsa_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_Total" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="es">Flujos Totales De Caja Netos Del Ejercicio</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaRiesgoDeTipoDeInteresDeLosFlujosDeEfectivoYDelValorRazonable_Standard" id="pharmamarsa_pharmamarsaRiesgoDeTipoDeInteresDeLosFlujosDeEfectivoYDelValorRazonable_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Riesgo De Tipo De Interes De Los Flujos De Efectivo Y Del Valor Razonable</label>
    <label xlink:label="label_pharmamarsa_pharmamarsaDisclosureOfDutyOfLoyalty_Standard" id="pharmamarsa_pharmamarsaDisclosureOfDutyOfLoyalty_Standard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="es">Disclosure Of Duty Of Loyalty</label>
  </labelLink>
</linkbase>